GovernmentU.S. health regulator
- Source type
- Government
- Access type
- Official
- Publisher
- U.S. Food and Drug Administration
- Added
- 2026-06-19
Trust profile
94
U.S. health regulator
- Publisher type
- Regulator
- Bias profile
- Low
Best used for
- Approvals
- Labels
- Safety communications
Weak for
- Comparative effectiveness
- Consumer experience
Used in Viral Vitalism
Regulatory statussignal4 references
GLP-1s Are Not Just a Weight Loss Story
Roles: Regulatory status
Claims supported
- FDA-approved GLP-1 products and compounded, unapproved, or falsely labeled products are different regulatory and quality-risk categories.
- Public GLP-1 claims are distorted by both promotional hype and categorical backlash, neither of which substitutes for indication-specific evidence.
Related studies
No structured study record is currently attached to this source.
Related sources
Trial registryClinical trial registry
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder
Trial registry for oral semaglutide among adults with AUD.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Trial registryClinical trial registry
Does Semaglutide Reduce Alcohol Intake
Trial registry for semaglutide and alcohol intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Trial registryClinical trial registry
Effects of Semaglutide on Nicotine Intake
Trial registry for semaglutide and nicotine intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 2 connections
Trial registryClinical trial registry
ESSENCE clinical trial registry
ClinicalTrials.gov used across the Viral Vitalism evidence library.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 3 connections
Trial registryGovernment health research
ESSENCE phase 3 trial design for semaglutide in MASH
PubMed used across the Viral Vitalism evidence library.
- Trust score
- 91
- Publisher
- PubMed
- Indexed by
- PubMed
- Access
- Abstract/index
- Usage
- 2 connections
Trial registryClinical trial registry
GLP-1R Agonist Treatment for Opioid Use Disorder
Trial registry testing whether semaglutide can reduce illicit opioid use in adults in outpatient OUD treatment.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Topic tags
glp-1compounded-glp-1consumer-safetyweight-loss